Autoimmune Diseases
Songqing Na, n/a
Senior research fellow
Eli Lilly & Company
San Diego, California, United States
Songqing Na, n/a
research scientist
Eli Lilly & Company
San Diego, California, United States
Songqing Na, n/a
Eli Lilly & Company
san diego, California, United States
jordan crampton, n/a
Eli Lilly and co
san diego, California, United States
zhen sun, n/a
Eli Lilly and co
Indianapolis, Indiana, United States
crystal Tang, n/a
Eli Lilly and Co
San Diego, California, United States
william chang, n/a
Eli Lilly and co
San Diego, California, United States
Kara kersjes, n/a
Eli Lilly and Co
san diego, California, United States
Rheumatoid arthritis (RA) and psoriatic arthritis pathobiology involves interplay between innate and adaptive immune components and resident synoviocytes. Single-cell analyses of patient samples and relevant mouse models have characterized many cellular subsets in RA. However, the impact of interactions between cell types is not fully understood. Here, we temporally profiled murine arthritic synovial isolates at the single-cell level to identify perturbations conserved in human RA. Notably, macrophage subtypes like those in RA patients were expanded in arthritis and linked to promoting the function of Th17 cells in the joint. In vitro experiments identified a capacity for macrophages to maintain the functionality and expansion of Th17 cells. Reciprocally, Th17-derived TNFa induced CD38+ macrophages that increased Th17 functionality. Synovial CD38+ macrophages were expanded during arthritis and their depletion or blockade via TNFa-neutralization alleviated disease while reducing IL-17A-producing cells. These findings identify a cellular feedback loop that promotes Th17 pathogenicity through TNFa to drive inflammatory arthritis.